Two Cases of Non-small Cell Lung Cancer Patients Treated with Allergen Removed Rhus Verniciflua Stokes Based Traditional Korean Medicine and Chemotherapy

알러젠 제거 옻나무 추출물 위주의 한방치료와 항암화학요법을 병용한 폐암 환자 2례

  • Kwon, Eun-Mi (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Jerng, Ui-Min (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Kim, Kyung-Suk (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Lee, Soo-Kyung (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Choi, Won-Cheol (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Yoon, Seong-Woo (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center)
  • 권은미 (경희대학교 동서신의학병원 한방암센터) ;
  • 정의민 (경희대학교 동서신의학병원 한방암센터) ;
  • 김경석 (경희대학교 동서신의학병원 한방암센터) ;
  • 이수경 (경희대학교 동서신의학병원 한방암센터) ;
  • 최원철 (경희대학교 동서신의학병원 한방암센터) ;
  • 윤성우 (경희대학교 동서신의학병원 한방암센터)
  • Published : 2009.12.28

Abstract

Lung cancer remains the leading cause of cancer-related death throughout the world. Non-small cell lung cancer(NSCLC) is the most deadly form of lung cancer. Patients with non-small cell lung cancer are often found to be unavailable for operation at primary diagnosis. They are typically given conventional chemotherapy. When the tumor progresses during chemotherapy, a change in regimen is considered. The average period of administration differs with the regimen. In this case report, the authors introduce two cases of non-small cell lung cancer patients treated with allergen removed Rhus verniciflua stokes based herbal medicine along with pemetrexed($Alimta^{(R)}$) and erlotinib($Tarceva^{(R)}$). The authors report this case because these molecular-targeted agents were used for longer periods than expected, while improving the performance and other symptoms. Further studies illuminating the synergistic effects through conjunctive treatment with both conventional and Eastern medicine in lung cancer treatment should be performed in the future.

Keywords